TransMedics Group, Inc.
TMDX
$87.72
-$0.52-0.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 11.83% | -4.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.83% | -4.85% | |||
| Cost of Revenue | 3.54% | 6.38% | |||
| Gross Profit | 18.35% | -12.15% | |||
| SG&A Expenses | 9.96% | -0.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.77% | 2.99% | |||
| Operating Income | 120.34% | -68.64% | |||
| Income Before Tax | 64.64% | -65.07% | |||
| Income Tax Expenses | 355.17% | 170.73% | |||
| Earnings from Continuing Operations | 62.64% | -65.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 62.64% | -65.43% | |||
| EBIT | 120.34% | -68.64% | |||
| EBITDA | 57.41% | -46.81% | |||
| EPS Basic | 61.86% | -65.75% | |||
| Normalized Basic EPS | 63.93% | -65.42% | |||
| EPS Diluted | 66.67% | -65.71% | |||
| Normalized Diluted EPS | 66.80% | -65.43% | |||
| Average Basic Shares Outstanding | 0.46% | 0.97% | |||
| Average Diluted Shares Outstanding | -1.33% | 1.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||